Results

Total Results: 1,524 records

Showing results for "drugs".

1161. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
      March 01, 2012 - For drugs like etidronate and sodium fluoride that could produce abnormal bone (osteomalacia) fracture … Based on a new RCT, we have added Teriparatide to the conclusion about drugs that effectively prevent … Yet these drugs are not included in the efficacy section. Delete. … These drugs have been omitted from the evidence table as they were deleted from the report. … A review of studies examining the characteristics of the drugs was beyond the scope of this project.

1162. Data-Points-8 Tables1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
      January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypretensive Drugs

1163. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
      January 01, 2014 - Should drugs be administered right before PCI, 6 hours prior, 12 hours prior if possible? … I found the descriptions of the classes of drugs very helpful. … This is already a very large report, and delving further into the background for these drugs is out … UFH given the small number of studies with a head-to- head comparison of those drugs. … However, in KQ 1, all three drugs were compared.

1164. The Refinement of Topics for Systematic Reviews: Lessons and Recommendations From the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
      January 01, 2013 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … PICO (Intervention): Corticosteroids; Synthetic disease- modifying anti- rheumatic drugs (DMARDs)

1165. CER 217 Management of Infertility Evidence Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
      May 01, 2019 - use of ovulation-induction agents including oral (clomiphene citrate or letrozole) and injected drugs … Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. … Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. … Effects of fertility drugs on cancers other than breast and gynecologic malignancies. … Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

1166. Microsoft Word - finbody.doc (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
      January 01, 2007 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … currently used interventions, including angioplasty with stent placement and/or those antihypertensive drugs … explicitly evaluated aggressive medical treatment with ACE inhibitors, statins, and anti-platelet drugs … after revascularization do occur in a small percentage of patients, and each of the antihypertensive drugs … eligibility criteria reported analyses of whether periprocedural interventions, such as different drugs

1167. Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
      October 01, 2017 - These reviews focus on a variety of issues, including assessing and comparing clinical drugs, treatments … I feel like the thing that I'm most struggling with from an evidence-based standpoint, is limiting pharmaceuticals … o What are the opportunities to substitute less costly, but equally effective, pharmaceuticals for specific … These reviews focus on a variety of issues, including comparing clinical drugs or treatments, and interventions … o Prevention strategies o Diagnostic strategies o Treatment strategies  Drugs, devices, non-pharmaceuticals

1168. uterine-fibroids-protocol-160301 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
      March 01, 2016 -  bleeding;;  In  vitro   fertilization;;  Precocious  puberty;;  Prostate  cancer   AstraZeneca   Pharmaceuticals … indications:     Endometrial  hyperplasia;;  Endometriosis;;   Menopausal  symptom   Bayer  Healthcare   Pharmaceuticals

1169. Hepatitis-C-Screening Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
      November 01, 2012 - injection drug users.16-22 About 60 percent of new infections occur in individuals who report injecting drugs … partners, unprotected sex, and/or sex with a person infected with HCV infection or using injection drugs … Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health

1170. Disposition of Comments Report for Evaluation and Treatment of Tinnitus (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_disposition-comments.pdf
      August 23, 2013 - Initially, these interventions were grouped together and labeled ‘medical’ because drugs and surgeries … I cannot see any advantage to lumping these drugs together but if you do want to group them, the only … We refer to gabapentin, baclofen, alprazolam, and acamprosate as neurotransmitter drugs and specify … Two of these feature experimental drugs that are not currently commercially available and this may be … Similarly, the grouping of antidepressants were in fact 4 different drugs with differing doses.

1171. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.

1172. Hypertension-Pulmonary-Arterial Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
      April 01, 2013 - These new data may clarify any effect on mortality and gauge the comparative effectiveness of these drugs … Additionally, combination drug therapy (using multiple drugs with different mechanisms of action) is … In order to 5 optimize PAH care, newer information regarding the latest drugs and combination therapies … compared a single drug (monotherapy) with placebo or standard therapy and included the following drugs … Drugs did not significantly differ in their odds of causing dizziness or diarrhea.

1173. Stroke-Atrial-Fibrillation Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
      August 01, 2013 - , Bleeding history or predisposition, Labile international normalized ratio, Elderly [>65 years], Drugs … Despite all the potential advantages of the new drugs demonstrated in the clinical trials when compared … with warfarin, the new drugs still do not have a well-validated and -studied immediate antidote. … The shorter half-life of the novel drugs may help in the management of bleeding episodes in patients … receiving these drugs and should provide comfort that bleeding can be controlled without an antidote

1174. Disposition of Comments for CER 165 Fecal Incontinence (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
      March 21, 2016 - For example, the easiest treatments to study (drugs) are not necessarily those that are used most … With diet drugs being 'symptom' and replacing sphincter being 'cure' - the issue would be what does … Stool modifying drugs are listed as BOTH pharmacological treatments and standard care treatments. … We assume that the Reviewer is referring to diet, over the counter drugs, PFMT, education, toileting … offers any advantage over standard care (such as dietary fiber supplementation, stool- modifying drugs

1175. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
      December 04, 2015 - that is currently available in the United States; we will assess the evidence for all uses of these drugs … We will search for clinical study reports from the European Medicines Agency, and search Drugs@FDA for … We will revise the inclusion/exclusion form from the original review (e.g., add conditions and new drugs … However, such an approach does not allow for comparisons between drugs that may not have much direct … evidence (e.g., drug A has been compared to drug B and C, but drugs B and C have not been directly

1176. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
      November 02, 2018 - pharmacological interventions, and nonprescription pharmacological interventions (e.g., over-the-counter drugs … claims abound on the internet and elsewhere about the cognitive benefits of dozens of over-the-counter drugs … Prescription Drugs Used for Treatment of CATD Cognition, Function, Quality of Life or BPSD Class of … inhibitors, NMDA antagonists, KQ 4-6: For targeting BPSD and quality of life outcomes: Prescription drugs … Since this outcome eliminated, drugs targeted to these symptoms should be eliminated.

1177. Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
      September 01, 2011 - support research with a focus on outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … “Treating Type 2 Diabetes, The Oral Diabetes Drugs, comparing Effectiveness, Safety, and Price.” … Consumer Reports Best Buy Drugs. Yonkers, NY: Consumers Union; 2006. 8.

1178. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1179. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1180. Cad-Pci-Bypass Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
      May 01, 2013 - CER #9: Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease Original release date: October 2007 Surveillance Report: May 2013 Key Findings: - New RCT and cohort studies further delineate which patients have improved outcome…